PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,672 stories, page 161 of 612

Advanced search
🌍Researchnews.uci.eduTier 2 · Direct publisher

UC Irvine School of Education to lead $10 million national center on AI and postsecondary writing

University of California IrvineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma firm plans expansion at former Hauppauge hotel site

Long Island Business NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HELP Committee report shows how abortion drug companies endanger women

liveaction.orgOriginal source
🌍Regulatoryacrohealth.orgTier 1 · Regulatory source

What the PDUFA VIII Framework Means for Clinical Research Organizations

ACRO AssociationOriginal source
🌍Industrynews.intermountainhealth.orgTier 3 · Secondary coverage

First in Utah: Intermountain Health Brings Innovative MRI Technology to Intermountain Medical Center to Enhance Care for Cancer & Heart Patients

<![CDATA[Intermountain Health Newsroom]]>Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Sangrail Debuts as New Biotech, Picks Up Dropped Gene Therapy for Sanfilippo Syndrome Type B

Precision Medicine OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A New Chapter for Families Living With GSDIa: From Pioneering Research to FDA Approval

UConn TodayOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company.

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

REP. BOEBERT INTRODUCES ADVANCING BOTANICAL DRUG DEVELOPMENT ACT OF 2026

House.govOriginal source
🇨🇦Researchnews.ubc.caTier 2 · Direct publisher

UBC welcomes nine world-leading researchers through Eddie Goldenberg Research Chairs of Canada program (Phase 1)

University of British ColumbiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lilly Targets China’s Obesity Market With New Phase 3 Oral Orforglipron Trial

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Has AI Forever Changed Governance Around PV Technology Use?

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eascra Biotech names former AbbVie exec as CSO

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Health Canada Launches Clinical Trial Search Portal and Registration and Results Disclosure Guidance

FaskenOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China-origin biotech assets and the hidden question of IP ownership

Life Sciences IP ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MBX Biosciences doses first patient in pivotal Phase 3 trial of once-weekly canvuparatide

DealroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna offers $2B in notes to fund cancer business, repay debt

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Next frontier: crystallising the future of medicines

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Next frontier: crystallising the future of medicines

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 2 · Trade media

What’s in Merck and Moderna’s cancer vaccine algorithm?

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma Fundamentals: Hold Times in Biopharmaceuticals, Risks and Regulations

PharmTech.comOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

General Medical Services Statement of Financial Entitlements Directions

Directions for the NHS from the Secretary of State for Health and Social Care relating to payments f...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA directs ban on sale of junk food within 50 metres in J&K schools

ET EducationOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Biotech funding has returned. The bar has moved with it.

pharmaphorumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Early trials for 'common cold' vaccine offer encouraging signs

Medical XpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Verrica Completes Enrollment in Phase 3 YCANTH Common Warts Trial

Dermatology TimesOriginal source
🌍Researchnews.uci.eduTier 2 · Direct publisher

Social media: Reading between the lines

University of California IrvineOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 30 August 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

TradingViewOriginal source
🌍Mediasaama.comTier 2 · Direct publisher

Architecting High-Velocity Healthcare Intelligence: Moving from Clinical Support to Total Orchestration

SaamaOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

Experiments Reveal “Critical Behavior” of Light

Heidelberg UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma Pulse: Medicaid Deals, GLP-1 Pullback, McKesson's Buy

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Targeted Drug Offers Hope in Pancreatic Cancer Treatment

University of Utah HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grand Pharmaceutical Group (SEHK:512) Stock Grapples With Profitability Reset

simplywall.stOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Osivax bags flu vaccine rights to pursue combination shot vision

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wall Street Moves on MAA, Rivian and Design Therapeutics: One Upgrade, One Target Trim and a Biotech on Watch

24/7 Wall St.Original source
🌍Industryapple.comTier 1 · Company source

Exciting updates for Sneaky Sasquatch come to Apple Arcade

Apple Health NewsroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 mRNA Cancer Vaccine Trial Delivers Positive Initial Results

Technology NetworksOriginal source
🌍discoverynews.google.comTier 2 · Trade media

After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform

Fierce BiotechOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: workforce management information July 2026

Reports on departmental staff numbers and costs.

UK Department of Health and Social CareOriginal source
🇺🇸CROmedpace.comTier 2 · Direct publisher

Inside the Lab: Advancing Clinical Laboratory Science Through Collaboration – Q&A with John M. Robbins, PhD

MedpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Takeda Pharmaceutical (TSE:4502) Is Getting Attention Today

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cassidy Exposes Lack of Action by Chemical Abortion Drug Companies

klax-tv.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharmalittle: We're reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more

STATOriginal source
🇺🇸Industryyprime.comTier 1 · Company source

IRT Case Study: Three Randomization Decisions, Preserving the Blind.

YPrimeOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Smart pathology slide scanner for diagnosis and patient-specific treatment recommendation in oncology

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

An Egyptian pharmaceutical firm is developing an Ebola vaccine

CTV NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

REPORT: Cassidy Exposes Abortion Drug Companies Endangering Mothers in New Report

Daily SignalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Proposes Mandatory GRAS Notification, but Stops Short of Premarket Approval

JD SupraOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference

The Manila TimesOriginal source
🌍Industryexozymes.comTier 1 · Company source

Slack Capital: Inside EXOZ’ strategic shift - building a compounding value flywheel

eXoZymesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ASNC2026 to Showcase Pivotal Phase 3 Trials Advancing Cardiac Amyloidosis Diagnosis and Treatment

The National Law ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Julie Akers named dean of the College of Pharmacy and Pharmaceutical Sciences

WSU InsiderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cassidy says abortion pill makers turn blind eye to safety

Roll CallOriginal source